← Back to Clinical Trials
Recruiting NCT04965025

Multi-stage Urethroplasty with Augmentation Using a Dorsal Graft Inlay Technique Comparing Graft Use in First or Second Stage

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Urethra Stenosis
Sponsor University Hospital, Ghent
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex MALE
Min Age 18 Years
Max Age N/A
Start Date 2020-11-11
Completion 2025-03-01
Interventions
Multi-stage urethroplasty with graft inlay in first stageMulti-stage urethroplasty with graft inlay in second stage

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The principal aim of this pilot study is to directly compare both approaches and analyze the failure rate after one year of follow-up. These data will serve as the basis to design a larger phase II or III trial in the future with failure rate as the primary end-point. Other study objectives are thoroughly described underneath.

Eligibility Criteria

Inclusion Criteria: * Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations. * Age ≥ 18 years. * Male patient. * Fit for operation, upon surgeon's discretion. * Isolated penile stricture that requires a multi-stage urethroplasty with dorsal inlay of a graft (upon surgeon's discretion). * Use of oral mucosa as graft material. * Patient is able and willing to comply with protocol. * Prior urethral surgery (dilation, urethrotomy of urethroplasty) is allowed. Exclusion Criteria: * Absence of signed written informed consent. * Age \< 18 years. * Female patients. * Transgender patients. * Patients unfit for operation. * Stricture disease extending beyond the penile urethra or concomitant stricture at a different urethral segment. * Use of graft other than oral mucosa. * Any condition or situation, which, in the investigator's opinion, puts the patient at significant risk, could confound the study result

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}